ATLANTA, Aug 16. -- Sciele Pharma, Inc. today announced that the U.S. Food & Drug Administration (FDA) has accepted the New Drug Application (NDA) submitted by Summers Laboratories for a head lice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback